Parkinson's Disease
Parkinson's disease is a progressive neurological disorder that affects movement, causing symptoms such as tremors, stiffness, and difficulty with balance and coordination.
Parkinson's Disease: Lecigon® Therapy
We are studying a new treatment combining levodopa and entacapone for people with Parkinson's disease. The goal is to see if it helps reduce certain symptoms and improve overall well-being compared to standard treatments.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have Parkinson's disease that started before you turned 65?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications for Parkinson's disease, like L-Dopa or dopamine agonists?
- Have you had any major mental health issues, like severe depression or active psychosis, in the past?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Carbidopa / Levodopa Brillpharma
Carbidopa/Levodopa Fair-Med
Co-Careldopa
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaetsklinikum Tuebingen AöR
, Department forNeurodegenerative Disease
Tübingen, Germany
Parkinson-Klinik Ortenau GmbH & Co. KG
Parkinson Klinik
Wolfach, Germany
Sponsor: Universitaetsklinikum Tuebingen AöR
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.